Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dienogest and CGRP levels in women with endometriosis pain
IRCT20220313054264N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of dienogest in endometriosis, sponsored by Iran University of Medical Sciences. Primary endpoints: Pain intensity and Pain frequency. Started Apr 2022; status: completed.
02
Drugs
dienogest
03
Conditions
endometriosis
Beyond the preview
Go deeper on IRCT20220313054264N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220313054264N1.